The trial enrolled 102 patients with metabolic-dysfunction-associated steatohepatitis. Credit: Emily frost / Shutterstock. Aligos Therapeutics has announced positive topline results from the Phase IIa ...

In Part A of the CIRRUS-HCM trial, patients with obstructive HCM received a single dose of 50, 100, or 200mg of EDG-7500. Credit: Inside Creative House/Shutterstock. Edgewise Therapeutics has ...

Antimicrobial drugs are widely used around the world to treat infections. However, the overuse of antimicrobials has resulted ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

There are a number of ongoing trials in mpox vaccines. Image credit: Shutterstock / Alexander56891. In August 2024, the World Health Organization (WHO) declared mpox a public health emergency of ...

Starton is planning larger Phase II trials for chronic lymphocytic leukaemia (CLL) and multiple myeloma in 2025. Credit: Ground Picture via Shutterstock. Starton Therapeutics has successfully ...

Patritumab deruxtecan’s safety profile in the trial was in line with previous lung cancer studies. Credit: Jo Panuwat D/Shutterstock. Daiichi Sankyo and MSD (Merck & Co) have reported that the Phase ...

Medtronic plans to use data from the ADAPT-PD trial to support the Percept PC’s aDBS global regulatory filing. Image credit: JHVEPhoto / Shutterstock. Medtronic has published preliminary data from a ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

The Phase III NIAGARA study evaluating AstraZeneca‘s Imfinzi (durvalumab) for neoadjuvant and adjuvant cisplatin-eligible muscle-invasive bladder cancer (MIBC) results were presented at European ...

Clinical data management companies support the process of data collection, validation, and preparation for statistical analysis for clinical trials. The need for efficient clinical trial data ...